DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness

Drugs for Neglected Diseases Initiative <media@dndi.org> Jun 12, 2026, 11:26 AM (12 days ago) to me DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness The registration follows successful clinical trials conducted in the DRC and Guinea and paves the way for use across all African countries where the most common form of the disease, caused by gambiense human African trypanosomiasis, is endemic. The medicine will be available free of charge to patients.

Published Recently
Published Earlier